BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Poland and Taiwan Turn Biotech Dialogue into Partnership at BIO Asia–Taiwan 2026

Poland and Taiwan moved to strengthen their biotechnology relationship at the Poland–Taiwan Biotechnology Forum, held on 17 July during BIO A...

July 20, 2026 | News

Canada and Taiwan Build New Bridges Across AI, Advanced Therapeutics and Precision Health

As biotechnology increasingly converges with artificial intelligence, advanced therapeutics and data-driven healthcare, the next generation of inno...

July 20, 2026 | News

Why Korea, Why Now? Korean Biotech Looks to Taiwan as Asia’s Next Partnership Frontier

Korea’s biotechnology industry is entering a new phase of global ambition. Having established significant capabilities across biopharmaceutical manuf...

July 20, 2026 | News

Japan Looks Beyond Its Borders to Build the Next Generation of Biotech Innovation

Japan’s biotechnology sector is entering a new phase in which scientific strength alone may no longer determine success. As drug development becomes ...

July 20, 2026 | News

Malaysia Positions Biotechnology as a Bridge Between Asian Innovation and Global Markets

As Asia’s biotechnology sector moves from scientific capability towards commercial scale, Malaysia is positioning itself as an increasingly i...

July 20, 2026 | News

India’s Life Sciences Proposition Expands from Global Scale to Strategic Innovation

India’s position in the global life sciences economy has long been anchored in scale — from active pharmaceutical ingredients (APIs) and generi...

July 20, 2026 | News

The Netherlands Positions Itself as Europe’s Gateway for Life Sciences Innovation

For biotechnology companies looking towards Europe, the opportunity is considerable—but so is the complexity. Accessing one of the world’s larg...

July 20, 2026 | News

Hong Kong Makes Its Case as Asia’s Biotech Super-Connector: Capital, Regulation and Scale Converge

Hong Kong is seeking to redefine its place in the global life sciences economy. No longer content to be viewed primarily as a financial gateway int...

July 20, 2026 | News

Australia and Taiwan Build a Faster Clinical Bridge for Global Biotech Development

As biotechnology companies face mounting pressure to move promising science into human studies faster, the relationship between Australia and Taiwa...

July 20, 2026 | News

Neurizon Completes Rapid Phase II/III NUZ-001 Enrolment for ALS with Results Expected in Q2 2027

250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in the HEALEY AL...

July 20, 2026 | News

Two Chairs, 11,000 Kilometres Apart: The Human Cost of Asia’s Plasma Dependence

REPORTAGE / PLASMA SUPPLY THE CHAIR The chair reclines. That is the first thing you notice, walking into a plasma centre in a strip mall on...

July 17, 2026 | Analysis

China Plus One: Slogan, Strategy, or Capacity APAC Does Not Have?

THE RESHUFFLE · ANALYSIS On a Monday in June 2026, one line in the United States Federal Register did what two year...

July 16, 2026 | Analysis

The Technology Is Ready. Are APAC’s Regulators?

In a process-development suite in Singapore, or Hyderabad, or Songdo, a perfusion bioreactor can now run for weeks, its output feeding straight into a conn...

July 15, 2026 | Regulatory

Q32 Bio Reports Positive Phase 2a Results for Bempikibart in Severe Alopecia Areata, Plans Pivotal Programme

-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline o...

July 15, 2026 | News

Stay Connected